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with surgical bypass, with shorter hospitalizations in symptomatic and
asymptomatic patients. Further long-term follow-up is required to compare
these two treatment modalities for durability to determine the optimal
popliteal aneurysm management.
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Objective(s): The goal was to create a multifactorial Disease Severity
Score (DSS) for characterization of femoropopliteal arterial lesions. By
having a greater understanding of the effect of patient comorbidities and an
in-depth method to characterize an arterial lesion, we may be able to better
compare lesions in different studies and predict which therapy is most
appropriate for each lesion undergoing an endovascular intervention (EVI).
Methods: We evaluated 44 lesion and patient characteristics in our
prospectively maintained lower extremity arterial lesion database from 2005
to 2009 to create a gradated DSS.
Results: We identified 1329 femoropopliteal lesions in 675 patients.
Statistical analysis by multivariable Cox proportional hazards model identi-
fied 16 variables that impact patency: seven lesion characteristics (Table I)
and nine patient characteristics or comorbidities (Table II). Factors with the
most impact were a chronic total occlusion (DSS 16), lesion length 100
mm (DSS 13), and no runoff vessels and stenosis of 80% to 99% (DSS 9).
The following factors were considered baseline, or score of 0: stenosis80%,
lesion length 100 mm, and three-vessel runoff. By adding these variable
scores, a DSS was created and used to predict patency of the EVI.
Conclusions: The presence of a chronic total occlusion, lesion
length 100 mm, poor runoff, and the presence of congestive heart
failure have the most dramatic effect on patency after EVI. A compre-
hensive DSS allows for the in-depth classification of lesion characteristics
and factors that predict success of EVI and can allow for comparison of
distinct lesions. Future comparisons of effectiveness of treatment modal-
ities can be possible.
Table I. Significant femoropopliteal lesion characteristics that negatively
impact patency after endovascular intervention
Factor Score HR (95% CI)
Chronic total occlusion 16 1.73 (1.28-2.33)
Stenosis 80%-90% 9 1.38 (1.06-1.78
Lesion length 100 mm 13 1.55 (1.25-1.93)
Vessel runoff
0 9 1.36 (0.95-1.96)
1 7 1.29 (0.96-1.73)
2 1 1.04 (0.77-1.40)
Lesion calcification 1 1.04 (0.82-1.31)
CI, Confidence interval; HR, hazard ratio.
Table II. Patient characteristics that impact patency after endovascular
intervention
Factor (N  16) Score Cox coefficient HR (95% CI)
CHF 8 0.274 1.32 (0.99-1.74)
Female sex 7 0.227 1.25 (0.96-1.63)
Current smoker 7 0.234 1.26 (0.80-1.99)
Former smoker 3 0.121 1.13 (0.85-1.50)
Diabetes 6 0.199 1.22 (0.94-1.58)
CAD 4 0.147 1.16 (0.88-1.53)
Renal 4 0.140 1.15 (0.85-1.55)
Age, years
50-64 6 0.195 1.22 (0.84-1.76)
65-79 2 0.075 0.93 (0.69-1.25)
CAD, Coronary artery disease; CHF, congestive heart failure; CI, confi-
dence interval; HR, hazard ratio.
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Objective(s): We compare the utility of endovascular therapy (ET)
with bypass surgery for critical limb ischemia (CLI) with tissue loss and
identify risk factors for failure of ET.
Table.
Hazard
ratio (HR/
AOR)
95% CI for HR/
AOR P value
Overall survival
Dialysis dependence 3.0 1.1–81. .03
Angina 5.1 1.3–20.3 .02
COPD 3.8 1.8–8.3 .001
Amputation free survival
Rutherford 6 3.6 1.4–9.2 .007
COPD 3.6 1.3–9.6 .01
Limb salvage
Rutherford 6 35.1 5.4–231 .0001
Wound healing at 12 months
Diabetes 7.0 1.4–36 .02
Current smoking 5.3 1.1–26 .04
Patency loss 4.8 1.1–22 .04
Methods: A retrospective review (2004 to 2010) of patients under-
going ET for tissue loss (Rutherford class 5 and 6) provided data for
multivariate models of overall survival, amputation-free survival (AFS),
limb salvage, and wound healing. Comparisons were made with a bypass
surgery cohort matched for tissue loss.
Results: Ninety-four patients underwent ET (58% TransAtlantic
InterSociety Concensus [TASC] C/D; 44% tibial) for Rutherford 5
(88%) or Rutherford 6 (12%) CLI with tissue loss of the heel (15%),
forefoot (16%), toe(s) (43%), calf/ankle (11%), or multiple locations
(15%). Sustained limb salvage was 83%  5%. Overall survival was 44% 
7% and AFS was 40% 7% at 2 years. Predictors of failure by multivariate
models are reported in the Table. Comparison between the Rutherford 5
WRsubgroup (n  83) and an Rutherford 5 bypass cohort (n  66),
suggest equivalent limb salvage, with reduced AFS (P  .04) and a trend
toward reduced overall survival (P  .09). Early would healing was
higher after bypass: 43% vs 11% at 3 months (P  .001) and 57% vs 30%
at 6 months (P  .01).
Conclusions: Given the short life expectancy of patients with tissue
loss, ET permits sustained limb salvage in patients at high risk for bypass
(particularly Rutherford 5). However, wound healing is slow compared
with bypass and requires sustained patency.
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Objective(s): This study evaluated the relationship of stent location on
limb salvage and stent patency in patients undergoing popliteal artery
stenting.
Methods: We performed a retrospective review of a prospectively
collected database, identifying all patients undergoing popliteal artery
stenting between September 2009 and February 2012. Patients were
divided into two groups based on the position of the distal end of the
stent in relation to the knee joint. The proximal popliteal stent group
included patients receiving a stent ending above the patella (above the
flexion point of the knee). The distal popliteal stent group included
patients receiving a stent(s) ending below the patella (in the flexion
zone). Data collected included demographics, indication for surgery,
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